Abstracts tagged "Lupus and cutaneous manifestations"

Abstract Number: 1809 • 2016 ACR/ARHP Annual Meeting
Influence of Solar Radiation in Cutaneous Manifestations of Lupus: Data from the Gladel Cohort
Marina Scolnik¹, Luis J. Catoggio¹, Enrique R. Soriano¹, Daniel Wojdyla², Alejandro Alvarellos³, Nilzio A Da Silva⁴, Eduardo Ferreira Borba⁵, Emilia Sato⁶, Antonio Iglesias-Gamarra⁷, Marlene Guibert-Toledano⁸, Sergio Jacobelli⁹, Ignacio Garcia de la Torre¹⁰, Maria Josefina Sauza del Pozo¹¹, Eduardo M. Acevedo-Vásquez¹², Maria H Esteva-Spinetti¹³, Graciela S. Alarcon¹⁴ and Bernado Pons-Estel¹⁵, ¹Rheumatology Section, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, ²GLADEL consultant, Rosario, Argentina, ³Hospital Privado de Córdoba, Servicio de Reumatologia, Cordoba, Argentina, ⁴Faculdade de Medicina da Universidade Federal de Goiás, Goiania, Brazil, ⁵Rheumatology, Hospital das Clinicas, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil, ⁶Rheumatology Div/Dept of Med, Escola Paulista de Medicina - Universidade Federal de São Paulo, Sao Paulo, Brazil, ⁷Facultad de Medicina, Universidad del Bosque, Bogota, Colombia, ⁸Centro de Investigaciones Médico Quirúrgicas, Habana, Centro de Investigaciones Médico Quirúrgicas, Habana, La Habana, Cuba, ⁹Medicine / Rheumatology, Pontificia Universidad Catolica de Chile, Santiago, Chile, ¹⁰Hospital General de Occidente, Guadalajara, Mexico, ¹¹Servicio de Reumatología, Instituto Mexicano de Seguro Social, Hospital de Especialidades Nº 25, Monterrey, Mexico, ¹²Hospital Nacional Guillermo Almenara Irigoyen, Lima, Peru, ¹³Unidad de Reumatología, Hospital Central de San Cristóbal, San Cristobal, Venezuela (Bolivarian Republic of), ¹⁴Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ¹⁵Sanatorio Parque, Rosario, Argentina
Background/Purpose: Classically, it has been thought that sun exposure is a risk factor for developing cutaneous manifestations in Systemic Lupus Erythematosus. On the other hand,…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].